2015
Macrolide Resistance in the Syphilis Spirochete, Treponema pallidum ssp. pallidum: Can We Also Expect Macrolide-Resistant Yaws Strains?
ŠMAJS, David, Lenka PAŠTĚKOVÁ a Linda GRILLOVÁZákladní údaje
Originální název
Macrolide Resistance in the Syphilis Spirochete, Treponema pallidum ssp. pallidum: Can We Also Expect Macrolide-Resistant Yaws Strains?
Autoři
ŠMAJS, David (203 Česká republika, garant, domácí), Lenka PAŠTĚKOVÁ (203 Česká republika, domácí) a Linda GRILLOVÁ (203 Česká republika, domácí)
Vydání
American Journal of Tropical Medicine and Hygiene, McLean, American Society of Tropical Medicine and Hygiene, 2015, 0002-9637
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30300 3.3 Health sciences
Stát vydavatele
Spojené státy
Utajení
není předmětem státního či obchodního tajemství
Impakt faktor
Impact factor: 2.453
Kód RIV
RIV/00216224:14110/15:00081041
Organizační jednotka
Lékařská fakulta
UT WoS
000362311800003
Klíčová slova anglicky
SINGLE-DOSE AZITHROMYCIN; COMPLETE GENOME SEQUENCE; RIBOSOMAL-RNA GENES; HUMAN-IMMUNODEFICIENCY-VIRUS; PENICILLIN-BINDING PROTEIN; TIME MULTIPLEX PCR; SECONDARY SYPHILIS; TREATMENT FAILURE; POINT MUTATION; ERYTHROMYCIN RESISTANCE
Štítky
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 5. 1. 2016 13:42, Ing. Mgr. Věra Pospíšilíková
Anotace
V originále
Treponema pallidum ssp. pallidum (TPA) causes over 10 million new cases of syphilis worldwide whereas T. pallidum ssp. pertenue (TPE), the causative agent of yaws, affects about 2.5 million people. Although penicillin remains the drug of choice in the treatment of syphilis, in penicillin-allergic patients, macrolides have been used in this indication since the 1950s. Failures of macrolides in syphilis treatment have been well documented in the literature and since 2000, there has been a dramatic increase in a number of clinical samples with macrolide-resistant TPA. Scarce data regarding the genetics of macrolide-resistant mutations in TPA suggest that although macrolideresistance mutations have emerged independently several times, the increase in the proportion of TPA strains resistant to macrolides is mainly due to the spread of resistant strains, especially in developed countries. The emergence of macrolide resistance in TPA appears to require a two-step process including either A2058G or A2059G mutation in one copy of the 23S rRNA gene and a subsequent gene conversion unification of both rRNA genes. Given the enormous genetic similarity that was recently revealed between TPA and TPE strains, there is a low but reasonable risk of emergence and spread of macrolide-resistant yaws strains following azithromycin treatment.
Návaznosti
GAP302/12/0574, projekt VaV |
|